Use access key #2 to skip to page content.
$2.57 -0.08 (-3.02%)
10/10/2008 3:58 PM

Trimeris, Inc. (TRMS)

CAPS Rating:
***

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of a new class of antiviral drug treatments called fusion inhibitors.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

Ticker Not Ratable

TRMS doesn't currently meet the $100M market cap / $1.50 stock price minimum. (Learn More)

What the Community Thinks

Total Members

67 Outperforms
8 Underperforms
 

All-Stars

15 Outperforms
3 Underperforms
 

Wall Street

0 Outperforms
1 Underperforms
 

Members bullish on TRMS are also bullish on:

Members bearish on TRMS are also bearish on:

Ticker Tags

Micro Cap (4824), Biotechnology (295)
Suggest a tag

Trimeris, Inc. At A Glance

Current Price: $2.57
Last Trade Time: 10/10/2008 3:58 PM
Open: $2.47
Previous Close: $2.65
Daily Range: $2.42 - $2.69
52-Week Range: $2.40 - $8.18
Volume: 53,159
Market Cap: $88.67M
P/E Ratio: 5.05
Compare Our Special Broker Offers!

Stock Trends

TRMS VS S&P 500 (SPY)

TRMS 12 month chart vs. S&P

News & Discussion Boards

Top Bull Pitch

Recs

2

Trimeris, Inc. (TRMS)

Avatar sleepyseth (99.08) Submitted: 11/07/06 4:10 PM

Buy this company before the earnings announcement. This will be their first quarter of steady positive earnings (actually their second positive quarter ever). The stock is down a lot over the past couple of years, but now the company is actually going to be profitable. The growth estimates look p...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 13 :   1 2 3 Next »

Recs

0

 (TRMS)

Avatar zzlangerhans (98.66) Submitted: 7/16/08 2:05 PM : Underperform Start Price: $5.70 TRMS Score: 26.90

Recent developments seem to indicate that Trimeris is planning to close up shop as Fuzeon sales diminish. They've terminated all R&D activity and are distributing out their cash to shareholders as dividends. Who would buy the company, and for what reason? Fuzeon has nowhere to go but down. The pick is a little complicated because I'm not sure how CAPS accounts for dividends, but I'm fairly sure the share price is eventually headed for the sub 1's. The only question is why it isn't there already.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (TRMS)

Avatar 1203cc (< 20) Submitted: 7/11/08 11:28 PM : Outperform Start Price: $5.91 TRMS Score: -27.09

I'm just here for the dividends


Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (TRMS)

Avatar tboneuva (31.95) Submitted: 5/01/08 10:27 AM : Outperform Start Price: $5.70 TRMS Score: -18.52

solid health care products company

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (TRMS)

Avatar WERDOSD44 (21.95) Submitted: 3/24/08 4:18 PM : Outperform Start Price: $5.09 TRMS Score: -15.10

THIS COMPANIES PROFITS HAVE DOUBLED

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (TRMS)

Avatar djinsanity (55.64) Submitted: 2/10/08 12:42 PM : Outperform Start Price: $5.34 TRMS Score: -18.35

Leader in anti-viral drug treatments, and the world will continue to fund this type of research, Leader in anti-HIV drug research.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 13 :   1 2 3 Next »

Wall Street

Results 1 - 1 of 1  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackZacks 80.22 10/29/07 Underperform 3M $5.91-56.55%-42.58%+13.97 Toggle the visibility of 60-Second Pitch and replies
TrackPiperJaff 78.50 10/12/06 Underperform NS $6.01-57.26%-34.70%+22.55

Results 1 - 1 of 1  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners